Federal, State and Local Officials In this section : Compliance, Enforcement & Training Manufacturing Electronic Submissions for

Federal, State and Local Officials In this section : Compliance, Enforcement & Training Manufacturing Electronic Submissions for

Federal Court Enters Consent Decree Against Pharmasol for Distributing Adulterated Drugs | FDA Skip to main content Skip

on input from a wide range of experts involved in manufacturing, distributing, purchasing, prescribing, and

Small Entity Compliance Guide: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary

Small Entity Compliance Guide: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary

Guidance for Industry: Assessing the Effects of Significant Manufacturing Process Changes, Including Emerging Technologies, on

the relevant courts to enter injunctions preventing those defendants from directly or indirectly manufacturing, selling, or distributing any

Lock and Enteral Syringes Due to a Change in Manufacturing | FDA Skip to

and Breeze Smoke, LLC who import and distribute Breeze products. These firms have been manufacturing, distributing, and/or

across the entire supply chain against unauthorized tobacco products and against those manufacturing, distributing, importing, or selling

and Breeze Smoke, LLC who import and distribute Breeze products. These firms have been manufacturing, distributing, and/or

on input from a wide range of experts involved in manufacturing, distributing, purchasing, prescribing, and

e-cigarettes. The FDA will continue to take appropriate action against those manufacturing, distributing, importing and

supplements.” The consent decrees prohibit Evig LLC and Premium Production LLC from distributing or manufacturing products until

FDA has issued more than 630 warning letters to firms for illegally manufacturing and/or

warning letters to three online retailers for selling and/or distributing unauthorized e-cigarettes that

the defendant companies and individuals from violating federal law by directly or indirectly manufacturing, selling, or distributing tobacco

the defendant companies and individuals from violating federal law by directly or indirectly manufacturing, selling, or distributing tobacco

the defendant companies and individuals from violating federal law by directly or indirectly manufacturing, selling, or distributing tobacco

the defendant companies and individuals from violating federal law by directly or indirectly manufacturing, selling, or distributing tobacco

adulterated because the devices were not manufactured in accordance with current good manufacturing practice requirements. In

adulterated because the devices were not manufactured in accordance with current good manufacturing practice requirements. In

adulterated because the devices were not manufactured in accordance with current good manufacturing practice requirements. In

adulterated because the devices were not manufactured in accordance with current good manufacturing practice requirements. In

any financial interests whatsoever in any aspect of the commercial device manufacturing/distributing industry, or release

FDA issued a warning letter to Amarillo Snuff Co. for manufacturing, selling, and/or

and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic

the FDA has issued more than 600 warning letters to firms for manufacturing and/or

in Heifers and Cows January 24, 2024 -  FDA Announces Draft Guidance on Good Manufacturing Practice for Active

in Heifers and Cows January 24, 2024 -  FDA Announces Draft Guidance on Good Manufacturing Practice for Active

in Heifers and Cows January 24, 2024 -  FDA Announces Draft Guidance on Good Manufacturing Practice for Active

and/or a court order requiring a company to stop manufacturing and distributing

warning letters to seven online retailers for selling and/or distributing unauthorized e-cigarettes. The

Veterinary Prescription Drugs December 14, 2023 -  Federal Court Enters Consent Decree Against Pharmasol for Distributing Adulterated Drugs December 14

Veterinary Prescription Drugs December 14, 2023 -  Federal Court Enters Consent Decree Against Pharmasol for Distributing Adulterated Drugs December 14

Actions - News Releases December 14, 2023 -  Federal Court Enters Consent Decree Against Pharmasol for Distributing Adulterated Drugs December 14

Actions - News Releases December 14, 2023 -  Federal Court Enters Consent Decree Against Pharmasol for Distributing Adulterated Drugs December 14

Actions - News Releases December 14, 2023 -  Federal Court Enters Consent Decree Against Pharmasol for Distributing Adulterated Drugs December 14

company, and Jennifer A. Richard, its chief executive officer, to stop distributing drugs until the

it has filed civil money penalty (CMP) complaints against four tobacco product manufacturers for manufacturing and selling

the suppliers. And as I previously said, if we determine that someone is manufacturing or distributing illicit, adulterated

The FDA’s review of the companies’ websites revealed that each firm is manufacturing and selling

use in all segments of the food industry from growing, harvesting, processing, manufacturing, distributing, and merchandising

decade ago and we expect that by using emerging science and good manufacturing practices companies will continue

and Drug Administration (FDA) conducted an inspection of your low-acid canned food manufacturing facility located at 221

are acting as a distributor and additional requirements apply. More information on manufacturing and distributing

CSA). The CSA established policy at the federal level on the manufacturing, distributing, importing, exporting, and

actions include issuing warning letters to two firms responsible for the manufacturing, distributing, and importing

Premarket Approval (PMA) PMA Quality System Share Post Linkedin Email Print On this page: Design Controls Manufacturing Controls Preapproval Inspection Postapproval

to manufacturers, importers, and distributors for illegally selling and/or distributing unauthorized new tobacco products

a licensing agreement with another manufacturer? Can the sponsor change the manufacturing site of the

medicated feed. Veterinary Feed Directives Veterinarians, clients (animal caretakers), manufacturers, and distributors authorizing, manufacturing, distributing, or using medicated feed

10, 2025, update: For a state-licensed pharmacy or physician compounding, dispensing or distributing semaglutide injection products under

a compliance period for certain modified risk tobacco product requirements. November 8, 2017: Stop manufacturing tobacco products, the

if occurring) are successful. In the United States, there are currently three companies manufacturing and distributing

as valsartan, losartan and irbesartan.  The warning letter outlines several current good manufacturing practice (CGMP) deviations at

use in all segments of the food industry from growing, harvesting, processing, manufacturing, distributing, and merchandising

10, 2025, update: For a state-licensed pharmacy or physician compounding, dispensing or distributing semaglutide injection products under

a compliance period for certain modified risk tobacco product requirements. November 8, 2017: Stop manufacturing tobacco products, the

manufacturers that the hand sanitizers were manufactured according to U.S. current good manufacturing practice requirements. This marks

do not meet the Current Good Manuf acturing Practice (CGMP) regulations for Manufacturing, Packaging, Labeling, or Holding

FSMA Proposed Rule for Preventive Controls for Animal Food Establish Current Good Manufacturing Practice and Hazard

reach the marketplace. Therefore, the FDA has not verified their safety, effectiveness, or manufacturing methods as part of

of Misbranded Drugs 2025/08/06 Three People Sentenced to Prison for Distributing Methamphetamine, Fentanyl and

effectiveness or quality. All drug compounders must comply with certain requirements, which can include current good manufacturing practice requirements, to

officers, Roya Panah and John W. Kosolcharoen, for processing and distributing unapproved products derived from

policies and procedures during specific types of inspection or for specific manufacturing processes. Foreign Inspections - Guide

policies and procedures during specific types of inspection or for specific manufacturing processes. Foreign Inspections - Guide

policies and procedures during specific types of inspection or for specific manufacturing processes. Foreign Inspections - Guide

policies and procedures during specific types of inspection or for specific manufacturing processes. Foreign Inspections - Guide

policies and procedures during specific types of inspection or for specific manufacturing processes. Foreign Inspections - Guide

policies and procedures during specific types of inspection or for specific manufacturing processes. Foreign Inspections - Guide

been prepared, packed or held under conditions that do not meet the Current Good Manufacturing Practice (CGMP) regulations for

During the inspection, we identified serious violations of the Current Good Manufacturing Practice (CGMP) in

the FDA has issued over 750 warning letters to firms for manufacturing, selling, or distributing unauthorized

own / cigarette tobacco products. 2 Summary of deeming related provision November 8, 2017 : stop manufacturing tobacco products, the

lapses in the quality of drugs and problems with their manufacturing that have the

announced additional recalls initiated by Medline Industries LP, a firm marketing and distributing plastic syringes made in

Tobacco Product Violation Small Business Assistance for Tobacco Product Industry Tobacco Retailer Warning Letters Manufacturing Retail Sales of

for its intended use, properly labeled, and manufactured according to current good manufacturing practices for animal

found a number of violations of the current Good Manufacturing Practice (cGMP) in

area of expertise (e.g. human food safety; environmental safety; target animal safety; effectiveness; biostatistics; chemistry, manufacturing and controls

medicated feed. Veterinary Feed Directives Veterinarians, clients (animal caretakers), manufacturers, and distributors authorizing, manufacturing, distributing, or using medicated feed

and Tomas Rizo. Among other requirements, the consent decree prohibits Rizo Lopez Foods from manufacturing and selling

area of expertise (e.g. human food safety; environmental safety; target animal safety; effectiveness; biostatistics; chemistry, manufacturing and controls

Medline Industries, LP and Sol-Millennium Medical, Inc., two firms marketing and distributing plastic syringes made in

during the inspection, FDA investigators documented evidence of significant deviations from current good manufacturing practice (CGMP) requirements, including

revealed serious violations of the FDA’s regulations for Current Good Manufacturing Practice (CGMP) in

The inspection revealed serious violations of FDA’s regulations for Current Good Manufacturing Practice (CGMP) in

pump. Issues with Certain Cardinal Health Monoject Syringes In June 2023, Cardinal Health began distributing Monoject syringes branded as

the syringes you are including in convenience kits, importing, and commercially distributing in the

the syringes you are including in convenience kits, importing, and commercially distributing in the

the syringes you are including in convenience kits, importing, and commercially distributing in the

the syringes you are including in convenience kits, importing, and commercially distributing in the

the syringes you are including in convenience kits, importing, and commercially distributing in the

revealed serious violations of the FDA’s regulations for Current Good Manufacturing Practice (CGMP) in

been prepared, packed, or held under conditions that do not meet the Current Good Manufacturing Practice (CGMP) regulations for

Boosted LLC. The consent decree prohibits Boosted LLC and Mr. Vigil from manufacturing, selling, or distributing any

U.S. Food and Drug Administration (FDA) has conducted an inspection of your manufacturing facility at 16136 W